Search results
Results from the WOW.Com Content Network
The big market story today is the return of Donald Trump. After being sworn in yesterday, Trump signed a flurry of executive orders whose impacts are rippling through the market.
Beginning in 2011, a contraceptive product based on RISUG, Vasalgel, was under development in the US by the Parsemus Foundation, who were unable to bring the product to market over the next decade. [3] In 2023, the patent for Vasalgel was acquired by NEXT Life Sciences, which plans to bring the technology to market under the name Plan A for Men ...
Stock market today: S&P 500, Dow end at record as investors shake off tariff fears, digest Fed minutes. Filip De Mott. November 26, 2024 at 4:21 PM. ... Gold rose by 0.41% to $2,629.3 an ounce.
U.S. stocks rose Tuesday after more companies said they made bigger profits at the end of last year than analysts expected and as Treasury yields eased. The S&P 500 climbed 0.9%, while many ...
Vasalgel was successful in achieving azoospermia in rabbits within 36 days of injection, as well as returned vas deferens patency. [9] In 2023, the patent for Vasalgel was acquired by NEXT Life Sciences, Inc., which plans to bring the technology to market under the name Plan A for Men. [10]
Technology stocks led a broad rally on Wall Street Tuesday during a holiday-shortened trading session ahead of Christmas. The Dow Jones Industrial Average added 0.9%, and the tech-heavy Nasdaq ...
Founded in 2005, Parsemus is an advocate of research into the plausibility of RISUG (and a method based on RISUG, called Vasalgel), a reversible male contraceptive. [2] [3] The foundation began procuring RISUG's United States intellectual property rights in November 2010, completed the acquisition process in February 2012, and is for the past 8 years conducting toxicology tests as an initial ...
The Dow Jones Industrial Average jumped 498 points, or 1.2%, and the Nasdaq composite gained 1%. Superstar stock Nvidia and other Big Tech companies led the market, which got a lift after a report ...